Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Other Non-Current Assets (2016 - 2021)

Historic Other Non-Current Assets for Ascendis Pharma A (ASND) over the last 10 years, with Q3 2021 value amounting to $2.0 million.

  • Ascendis Pharma A's Other Non-Current Assets rose 3913.43% to $2.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 million, marking a year-over-year increase of 3913.43%. This contributed to the annual value of $1.6 million for FY2020, which is 123.64% up from last year.
  • Per Ascendis Pharma A's latest filing, its Other Non-Current Assets stood at $2.0 million for Q3 2021, which was up 3913.43% from $2.0 million recorded in Q2 2021.
  • In the past 5 years, Ascendis Pharma A's Other Non-Current Assets ranged from a high of $6.6 million in Q3 2019 and a low of -$987307.9 during Q4 2018
  • Over the past 5 years, Ascendis Pharma A's median Other Non-Current Assets value was $1.6 million (recorded in 2019), while the average stood at $2.6 million.
  • Within the past 5 years, the most significant YoY rise in Ascendis Pharma A's Other Non-Current Assets was 5405396.16% (2018), while the steepest drop was 143099.36% (2018).
  • Quarter analysis of 5 years shows Ascendis Pharma A's Other Non-Current Assets stood at $74178.3 in 2017, then tumbled by 1430.99% to -$987307.9 in 2018, then skyrocketed by 264.02% to $1.6 million in 2019, then rose by 1.24% to $1.6 million in 2020, then increased by 23.22% to $2.0 million in 2021.
  • Its Other Non-Current Assets stands at $2.0 million for Q3 2021, versus $2.0 million for Q2 2021 and $1.6 million for Q4 2020.